4DX
4DMedical Ltd
Health Care Technology
·
Healthcare
3
comments
3
fund managers
past 90 days
About 4DMedical Ltd
4DMedical Ltd. is an Australian medical technology company founded in 2012 by Andreas Fouras. Headquartered in Carlton, the company commercializes the XV Technology platform, a four-dimensional lung imaging solution. 4DMedical develops a pipeline of diagnostic tools designed to assist physicians in managing lung disease. Key products include XV ventilation analysis, ventilation perfusion, contrast-free pulmonary angiography, small animal ventilators, and preclinical scanners. These proprietary technologies provide detailed functional lung imaging to improve clinical decision-making and patient outcomes.
Commentary Volume
3
Comments
3
Fund managers
0
Past 90 days
SOURCE
ACTION
COMMENT PREVIEW
FUND MANAGER
DATE
Loading...
.
​Loading...
Loading...
Loading...
Loading...
Source: Ipsum Capital Q4 Quarterly Letter · Published 14 March 2025
Report a problem
Loading...
.
Loading...
Loading...
Loading...
Loading...
§ Important Notice
The entries below are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Commentary
Sector
Healthcare
Market cap
$2B
Fund managers
3 managers
First covered
31 Dec 2025
Last updated
30 Apr 2026
Company Details
Related Themes
ic
Ipsum Capital
6 comments
ic
Amet Funds
4 comments
ic
Dolor
3 comments
Top Investors Covering MIN
§ Reminder
The entries above are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Frequently asked questions about 4DMedical Ltd (ASX:4DX)
Frequently asked questions
Who is investing in 4DMedical Ltd (ASX:4DX)?
Fund managers including ELM Responsible Investments have invested in 4DMedical Ltd (ASX:4DX).
What is the short interest in 4DMedical Ltd (ASX:4DX)?
The short interest in 4DMedical Ltd (ASX:4DX) is 6.86% which makes it the 37th most shorted stock on the ASX. Of the 592.7M shares that 4DMedical Ltd has on issue, 40.7M have been sold short.
What does 4DMedical Ltd (ASX:4DX) do?
4DMedical Ltd. is an Australian medical technology company founded in 2012 by Andreas Fouras. Headquartered in Carlton, the company commercializes the XV Technology platform, a four-dimensional lung imaging solution. 4DMedical develops a pipeline of diagnostic tools designed to assist physicians in managing lung disease. Key products include XV ventilation analysis, ventilation perfusion, contrast-free pulmonary angiography, small animal ventilators, and preclinical scanners. These proprietary technologies provide detailed functional lung imaging to improve clinical decision-making and patient outcomes.
Loading...